HealthMore in Health→
Supreme Court Ruling Backs Hikma in Skinny-Label Case
Key Takeaways
- The Supreme Court unanimously ruled in favor of Hikma Pharmaceutical.
- The case concerns patent claims tied to so-called skinny labeling.
- The decision could shape future litigation involving generic drug launches.
DE
DT Editorial Team··via statnews.com
